96
Views
4
CrossRef citations to date
0
Altmetric
Original Scientific Papers

The non-HDL-C/HDL-C ratio is a strong and independent predictor of the no-reflow phenomenon in patients with ST-elevation myocardial infarction

ORCID Icon, , , , , , , & show all
Pages 194-205 | Received 14 May 2023, Accepted 15 Dec 2023, Published online: 04 Jan 2024

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kenan Toprak, İbrahim Halil Toprak, Osman Acar & Mehmet Fatih Ermiş. (2024) The predictive value of the HALP score for no-reflow phenomenon and short-term mortality in patients with ST-elevation myocardial infarction. Postgraduate Medicine 0:0, pages 1-11.
Read now
Patrizio Lancellotti. (2024) Acute and chronic coronary artery disease. Acta Cardiologica 79:2, pages 105-108.
Read now

Articles from other publishers (2)

Mehrdad Rabiee Rad, Ghazal Ghasempour Dabaghi, Bahar Darouei & Reza Amani-Beni. (2024) The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis. Cardiovascular Diabetology 23:1.
Crossref
Kenan Toprak, Mustafa Kaplangoray, Mehmet Inanır, Ayten Dursun, Mustafa Begenc Tascanov, Ibrahim Halil Altıparmak, Asuman Biçer & Recep Demirbag. (2024) Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction. Angiology.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.